Business Companies 14 Feb 2017 Sun Pharma Q3 net pr ...

Sun Pharma Q3 net profit slips 5 per cent to Rs 1,471 crore

PTI
Published Feb 14, 2017, 4:08 pm IST
Updated Feb 14, 2017, 4:09 pm IST
Shares of Sun Pharmaceutical Industries were trading at Rs 654.55 per scrip on BSE.
Consolidated total income from operations, however, rose to Rs 7,912.66 crore for the quarter under review.
 Consolidated total income from operations, however, rose to Rs 7,912.66 crore for the quarter under review.

New Delhi: Drug major Sun Pharmaceutical today reported a 4.72 per cent decline in its consolidated net profit to Rs 1,471.82 crore for the third quarter ended December 31, 2016.

The company had posted a net profit after taxes, non-controlling interest and share of profit of associates and joint ventures of Rs 1,544.85 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.

 

Consolidated total income from operations, however, rose to Rs 7,912.66 crore for the quarter under review, as against Rs 7122.31 crore in the same period a year ago.

Shares of Sun Pharmaceutical Industries were trading at Rs 654.55 per scrip on BSE, down 0.06 per cent from its previous close.

...
Location: India, Delhi, New Delhi




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
-->